Shares of Homology Medicines Inc (NASDAQ:FIXX) have been given an average recommendation of “Buy” by the six research firms that are currently covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month price target among […]